Prediction of New Onset Diabetes after Liver Transplant
  25% of people who received a liver transplant will go on to develop diabetes
within the next 5 years. These thousands of individuals are at 2-fold higher
risk of cardiovascular events, graft loss, infections, as well as lower
long-term survival. This is partly due to the medication used during and/or
after transplant that significantly impacts metabolic balance. To assess which
medication best suits the patient's condition, clinicians need an accurate
estimate of diabetes risk. Both patient's historical data and observations at
the current visit are informative in predicting whether the patient will
develop diabetes within the following year. In this work we compared a variety
of time-to-event prediction models as well as classifiers predicting the
likelihood of the event within a year from the current checkup. We are
particularly interested in comparing two types of models: 1) standard
time-to-event predictors where the historical measurements are merely
concatenated, 2) incorporating Deep Markov Model to first obtain
low-dimensional embedding of historical data and then using this embedding as
an additional input into the model. We compared a variety of algorithms
including standard and regularized Cox proportional-hazards model (CPH), mixed
effect random forests, survival-forests and Weibull Time-To-Event Recurrent
Neural Network (WTTE-RNN). The results show that although all methods'
performances varied from year to year and there was no clear winner across all
the time points, regularized CPH model that used 1 to 3 years of historical
visits data on average achieved a high, clinically relevant Concordance Index
of .863. We thus recommend this model for further prospective clinical
validation and hopefully, an eventual use in the clinic to improve clinicians'
ability to personalize post-operative care and reduce the incidence of
new-onset diabetes post liver transplant.
